ProCA32.Collagen
Pre-clinical- Indications
- Liver fibrosis
Company intelligence / Profile preview
InLighta BioSciences
Marietta, Georgia, United Statesinlighta.com ↗
- Ownership
- Private
- Development stage
- Preclinical
01
Overview
InLighta BioSciences develops a novel class of protein-based MRI contrast agents with improved in vivo imaging capabilities. Their ProCA® platform enables both blood pool and targeted molecular imaging for early disease detection—especially small tumors and fibrotic tissue—with higher sensitivity/specificity than traditional metal-based dyes. The technology has shown promise in pre-clinical models for detecting cancer subtypes/heterogeneity as well as reversible liver fibrosis. The company’s approach offers safer alternatives to biopsy or radioisotopes due to lower toxicity risk.
- Therapeutic areas
- OncologyGastroenterology
- Modalities
- Protein-based contrast agents (ProCA® series)Blood pool agents (non-targeted)Targeted molecular imaging agents
- Industry
- Medical Imaging
02
Drug pipeline
3 assets2 more assets in the full pipeline.
Request access →Beyond the preview
Go deeper on InLighta BioSciences.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on InLighta BioSciences.